The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

The dual-track analysis confirms that the Jordanian Paradox is influenced by deeply rooted, intersecting institutional ...